Author

L. Jarvis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Coles· 1 shared C. M. Gaunt· 1 shared D. Rainbow· 1 shared H. Mousa· 1 shared J. L. Jones· 1 shared N. Cunniffe· 1 shared R. MacKenzie· 1 shared W. Brown· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Coles

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The MS remyelinating drug bexarotene (an RXR agonist) promotes induction of human Tregs and suppresses Th17 differentiation in vitro

C. M. Gaunt, D. Rainbow, R. MacKenzie, L. Jarvis, H. Mousa, N. Cunniffe, Z. Georgieva, W. Brown, A. Coles, J. L. Jones

This study shows bexarotene, an RXR agonist, promotes Treg induction and suppresses Th17 differentiation in human CD4 T cells, independent of tRA and RAR signaling.

bioRxiv · Feb 17, 2021Immunology